Theravance Biopharma Aktie
Finanztrends
Deine Einschätzung
Theravance Biopharma Aktie
Ein signifikanter Verlust für Theravance Biopharma heute, um -1,15 %.
Was spricht für und gegen Theravance Biopharma in den nächsten Jahren?
Pro
?
L*********** I********** f** d** n******* J****
?
U****************
?
M****
Kontra
?
W******* i* V********
?
A****************
?
M************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Theravance Biopharma im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma | -1,15 % | 6,41 % | 11,41 % | 100,00 % | 5,73 % | 59,62 % | 17,73 % |
| Rockwell Medical Inc. | -2,13 % | 6,86 % | 5,45 % | -57,46 % | 24,39 % | -49,91 % | -92,57 % |
| Pacira Pharmaceuticals | -0,54 % | -9,72 % | -8,88 % | -4,41 % | -9,72 % | -42,65 % | -66,95 % |
| Twist Bioscience Corp | 0,72 % | 9,44 % | 31,03 % | -18,94 % | 24,02 % | 44,16 % | -75,15 % |
Kommentare
News
Here's Why Shares in Theravance Biopharma Exploded Today
Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue